Copyright Reports & Markets. All rights reserved.

Global HPV Genetic Testing Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of HPV Genetic Testing by Type
    • 1.3.1 Overview: Global HPV Genetic Testing Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global HPV Genetic Testing Consumption Value Market Share by Type in 2024
    • 1.3.3 HC-Ⅱ
    • 1.3.4 DNA Microarray
    • 1.3.5 Real-time PCR
  • 1.4 Global HPV Genetic Testing Market by Application
    • 1.4.1 Overview: Global HPV Genetic Testing Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Genital Warts Diagnosis
    • 1.4.3 Cervical Cancer Diagnosis
    • 1.4.4 Other
  • 1.5 Global HPV Genetic Testing Market Size & Forecast
  • 1.6 Global HPV Genetic Testing Market Size and Forecast by Region
    • 1.6.1 Global HPV Genetic Testing Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global HPV Genetic Testing Market Size by Region, (2020-2031)
    • 1.6.3 North America HPV Genetic Testing Market Size and Prospect (2020-2031)
    • 1.6.4 Europe HPV Genetic Testing Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific HPV Genetic Testing Market Size and Prospect (2020-2031)
    • 1.6.6 South America HPV Genetic Testing Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa HPV Genetic Testing Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 BGI Group
    • 2.1.1 BGI Group Details
    • 2.1.2 BGI Group Major Business
    • 2.1.3 BGI Group HPV Genetic Testing Product and Solutions
    • 2.1.4 BGI Group HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 BGI Group Recent Developments and Future Plans
  • 2.2 Vcanbio Cell and Gene Engineering Corp
    • 2.2.1 Vcanbio Cell and Gene Engineering Corp Details
    • 2.2.2 Vcanbio Cell and Gene Engineering Corp Major Business
    • 2.2.3 Vcanbio Cell and Gene Engineering Corp HPV Genetic Testing Product and Solutions
    • 2.2.4 Vcanbio Cell and Gene Engineering Corp HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Vcanbio Cell and Gene Engineering Corp Recent Developments and Future Plans
  • 2.3 Oxford Nanopore Technologies
    • 2.3.1 Oxford Nanopore Technologies Details
    • 2.3.2 Oxford Nanopore Technologies Major Business
    • 2.3.3 Oxford Nanopore Technologies HPV Genetic Testing Product and Solutions
    • 2.3.4 Oxford Nanopore Technologies HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Oxford Nanopore Technologies Recent Developments and Future Plans
  • 2.4 PacBio
    • 2.4.1 PacBio Details
    • 2.4.2 PacBio Major Business
    • 2.4.3 PacBio HPV Genetic Testing Product and Solutions
    • 2.4.4 PacBio HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 PacBio Recent Developments and Future Plans
  • 2.5 Macrogen
    • 2.5.1 Macrogen Details
    • 2.5.2 Macrogen Major Business
    • 2.5.3 Macrogen HPV Genetic Testing Product and Solutions
    • 2.5.4 Macrogen HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Macrogen Recent Developments and Future Plans
  • 2.6 Bruker
    • 2.6.1 Bruker Details
    • 2.6.2 Bruker Major Business
    • 2.6.3 Bruker HPV Genetic Testing Product and Solutions
    • 2.6.4 Bruker HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Bruker Recent Developments and Future Plans
  • 2.7 QIAGEN
    • 2.7.1 QIAGEN Details
    • 2.7.2 QIAGEN Major Business
    • 2.7.3 QIAGEN HPV Genetic Testing Product and Solutions
    • 2.7.4 QIAGEN HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 QIAGEN Recent Developments and Future Plans
  • 2.8 10X Genomics
    • 2.8.1 10X Genomics Details
    • 2.8.2 10X Genomics Major Business
    • 2.8.3 10X Genomics HPV Genetic Testing Product and Solutions
    • 2.8.4 10X Genomics HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 10X Genomics Recent Developments and Future Plans
  • 2.9 Agilent Technologies
    • 2.9.1 Agilent Technologies Details
    • 2.9.2 Agilent Technologies Major Business
    • 2.9.3 Agilent Technologies HPV Genetic Testing Product and Solutions
    • 2.9.4 Agilent Technologies HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Agilent Technologies Recent Developments and Future Plans
  • 2.10 Illumina
    • 2.10.1 Illumina Details
    • 2.10.2 Illumina Major Business
    • 2.10.3 Illumina HPV Genetic Testing Product and Solutions
    • 2.10.4 Illumina HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Illumina Recent Developments and Future Plans
  • 2.11 Thermo Fisher Scientific
    • 2.11.1 Thermo Fisher Scientific Details
    • 2.11.2 Thermo Fisher Scientific Major Business
    • 2.11.3 Thermo Fisher Scientific HPV Genetic Testing Product and Solutions
    • 2.11.4 Thermo Fisher Scientific HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.12 Testing
    • 2.12.1 Testing Details
    • 2.12.2 Testing Major Business
    • 2.12.3 Testing HPV Genetic Testing Product and Solutions
    • 2.12.4 Testing HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Testing Recent Developments and Future Plans
  • 2.13 LifeLabs
    • 2.13.1 LifeLabs Details
    • 2.13.2 LifeLabs Major Business
    • 2.13.3 LifeLabs HPV Genetic Testing Product and Solutions
    • 2.13.4 LifeLabs HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 LifeLabs Recent Developments and Future Plans
  • 2.14 GenPath Diagnostics
    • 2.14.1 GenPath Diagnostics Details
    • 2.14.2 GenPath Diagnostics Major Business
    • 2.14.3 GenPath Diagnostics HPV Genetic Testing Product and Solutions
    • 2.14.4 GenPath Diagnostics HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 GenPath Diagnostics Recent Developments and Future Plans
  • 2.15 Hologic Women's Health
    • 2.15.1 Hologic Women's Health Details
    • 2.15.2 Hologic Women's Health Major Business
    • 2.15.3 Hologic Women's Health HPV Genetic Testing Product and Solutions
    • 2.15.4 Hologic Women's Health HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Hologic Women's Health Recent Developments and Future Plans
  • 2.16 Mayo Clinic
    • 2.16.1 Mayo Clinic Details
    • 2.16.2 Mayo Clinic Major Business
    • 2.16.3 Mayo Clinic HPV Genetic Testing Product and Solutions
    • 2.16.4 Mayo Clinic HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Mayo Clinic Recent Developments and Future Plans
  • 2.17 Enzo Biochem
    • 2.17.1 Enzo Biochem Details
    • 2.17.2 Enzo Biochem Major Business
    • 2.17.3 Enzo Biochem HPV Genetic Testing Product and Solutions
    • 2.17.4 Enzo Biochem HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Enzo Biochem Recent Developments and Future Plans
  • 2.18 Seegene
    • 2.18.1 Seegene Details
    • 2.18.2 Seegene Major Business
    • 2.18.3 Seegene HPV Genetic Testing Product and Solutions
    • 2.18.4 Seegene HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Seegene Recent Developments and Future Plans
  • 2.19 The BioArte
    • 2.19.1 The BioArte Details
    • 2.19.2 The BioArte Major Business
    • 2.19.3 The BioArte HPV Genetic Testing Product and Solutions
    • 2.19.4 The BioArte HPV Genetic Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 The BioArte Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global HPV Genetic Testing Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of HPV Genetic Testing by Company Revenue
    • 3.2.2 Top 3 HPV Genetic Testing Players Market Share in 2024
    • 3.2.3 Top 6 HPV Genetic Testing Players Market Share in 2024
  • 3.3 HPV Genetic Testing Market: Overall Company Footprint Analysis
    • 3.3.1 HPV Genetic Testing Market: Region Footprint
    • 3.3.2 HPV Genetic Testing Market: Company Product Type Footprint
    • 3.3.3 HPV Genetic Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global HPV Genetic Testing Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global HPV Genetic Testing Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global HPV Genetic Testing Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global HPV Genetic Testing Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America HPV Genetic Testing Consumption Value by Type (2020-2031)
  • 6.2 North America HPV Genetic Testing Market Size by Application (2020-2031)
  • 6.3 North America HPV Genetic Testing Market Size by Country
    • 6.3.1 North America HPV Genetic Testing Consumption Value by Country (2020-2031)
    • 6.3.2 United States HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 6.3.3 Canada HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico HPV Genetic Testing Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe HPV Genetic Testing Consumption Value by Type (2020-2031)
  • 7.2 Europe HPV Genetic Testing Consumption Value by Application (2020-2031)
  • 7.3 Europe HPV Genetic Testing Market Size by Country
    • 7.3.1 Europe HPV Genetic Testing Consumption Value by Country (2020-2031)
    • 7.3.2 Germany HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 7.3.3 France HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 7.3.5 Russia HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 7.3.6 Italy HPV Genetic Testing Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific HPV Genetic Testing Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific HPV Genetic Testing Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific HPV Genetic Testing Market Size by Region
    • 8.3.1 Asia-Pacific HPV Genetic Testing Consumption Value by Region (2020-2031)
    • 8.3.2 China HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 8.3.3 Japan HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 8.3.5 India HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 8.3.7 Australia HPV Genetic Testing Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America HPV Genetic Testing Consumption Value by Type (2020-2031)
  • 9.2 South America HPV Genetic Testing Consumption Value by Application (2020-2031)
  • 9.3 South America HPV Genetic Testing Market Size by Country
    • 9.3.1 South America HPV Genetic Testing Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina HPV Genetic Testing Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa HPV Genetic Testing Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa HPV Genetic Testing Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa HPV Genetic Testing Market Size by Country
    • 10.3.1 Middle East & Africa HPV Genetic Testing Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia HPV Genetic Testing Market Size and Forecast (2020-2031)
    • 10.3.4 UAE HPV Genetic Testing Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 HPV Genetic Testing Market Drivers
  • 11.2 HPV Genetic Testing Market Restraints
  • 11.3 HPV Genetic Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 HPV Genetic Testing Industry Chain
  • 12.2 HPV Genetic Testing Upstream Analysis
  • 12.3 HPV Genetic Testing Midstream Analysis
  • 12.4 HPV Genetic Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global HPV Genetic Testing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

    This report is a detailed and comprehensive analysis for global HPV Genetic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global HPV Genetic Testing market size and forecasts, in consumption value ($ Million), 2020-2031
    Global HPV Genetic Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global HPV Genetic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global HPV Genetic Testing market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for HPV Genetic Testing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global HPV Genetic Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BGI Group, Vcanbio Cell and Gene Engineering Corp, Oxford Nanopore Technologies, PacBio, Macrogen, Bruker, QIAGEN, 10X Genomics, Agilent Technologies, Illumina, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    HPV Genetic Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    HC-Ⅱ
    DNA Microarray
    Real-time PCR
    Market segment by Application
    Genital Warts Diagnosis
    Cervical Cancer Diagnosis
    Other
    Market segment by players, this report covers
    BGI Group
    Vcanbio Cell and Gene Engineering Corp
    Oxford Nanopore Technologies
    PacBio
    Macrogen
    Bruker
    QIAGEN
    10X Genomics
    Agilent Technologies
    Illumina
    Thermo Fisher Scientific
    Testing
    LifeLabs
    GenPath Diagnostics
    Hologic Women's Health
    Mayo Clinic
    Enzo Biochem
    Seegene
    The BioArte
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe HPV Genetic Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of HPV Genetic Testing, with revenue, gross margin, and global market share of HPV Genetic Testing from 2020 to 2025.
    Chapter 3, the HPV Genetic Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and HPV Genetic Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of HPV Genetic Testing.
    Chapter 13, to describe HPV Genetic Testing research findings and conclusion.

    Buy now